Insiders Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 17/06/2025 BST			5-day change	1st Jan Change
308.71 ^USD	-0.02%		+1.55%	+31.19%

06-09	Alnylam Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 09:20 AM
06-09	Alnylam Gets EU Approval for RNAi Drug to Treat Transthyretin Amyloidosis With Cardiomyopathy	MT

Insiders

Transcode Therapeutics Appoints Dr. Phillip D. Zamore to Science Advisory Board	05-28	CI
Alnylam Pharmaceuticals Insider Sold Shares Worth $3,124,217, According to a Recent SEC Filing	05-19	MT
Alnylam Pharmaceuticals, Inc. Announces Retirement of Phillip A. Sharp from the Board of Directors, Effective May 8, 2025	03-05	CI
Alnylam Pharmaceuticals Insider Sold Shares Worth $787,904, According to a Recent SEC Filing	02-18	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $531,448, According to a Recent SEC Filing	02-18	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $309,527, According to a Recent SEC Filing	02-18	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $14,988,720, According to a Recent SEC Filing	01-29	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $439,760, According to a Recent SEC Filing	12-13	MT
TransMedics Names Gerardo Hernandez as CFO; Shares Fall	12-03	MT
TransMedics Names Gerardo Hernandez as CFO; Updates Full Year 2024 Guidance	12-02	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing	11-27	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing	11-27	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing	11-27	MT
KalVista Pharmaceuticals, Inc. Appoints Laurence Reid to Board of Directors	11-26	CI
Lexeo Therapeutics, Inc. Appoints Tolga Tanguler to Its Board of Directors	11-13	CI
Cognizant Selected as Alnylam's IT Services Provider	29/10/24	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $4,200,000, According to a Recent SEC Filing	23/08/24	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $4,089,960, According to a Recent SEC Filing	05/08/24	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,851,273, According to a Recent SEC Filing	15/07/24	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $370,747, According to a Recent SEC Filing	26/06/24	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,917,475, According to a Recent SEC Filing	26/06/24	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $485,773, According to a Recent SEC Filing	26/06/24	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $7,161,360, According to a Recent SEC Filing	26/06/24	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $3,224,546, According to a Recent SEC Filing	03/06/24	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $4,540,071, According to a Recent SEC Filing	01/03/24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Pharmaceuticals

Insiders

Filters